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In vitro two-dimensional (2D) and three-dimensional (3D) cultivation of mammalian cells
requires supplementation with serum. Mesenchymal stem cells (MSCs) are widely used
in clinical trials for bioregenerative medicine and in most cases, in vitro expansion and
differentiation of these cells are required before application. Optimized expansion and
differentiation protocols play a key role in the treatment outcome. 3D cell cultivation
systems are more comparable to in vivo conditions and can provide both, more
physiological MSC expansion and a better understanding of intercellular and cell-matrix
interactions. Xeno-free cultivation conditions minimize risks of immune response after
implantation. Human platelet lysate (hPL) appears to be a valuable alternative to widely
used fetal calf serum (FCS) since no ethical issues are associated with its harvest, it
contains a high concentration of growth factors and cytokines and it can be produced
from expired platelet concentrate. In this study, we analyzed and compared proliferation,
as well as osteogenic and chondrogenic differentiation of human adipose tissue-derived
MSCs (hAD-MSC) using three different supplements: FCS, human serum (HS), and
hPL in 2D. Furthermore, online monitoring of osteogenic differentiation under the
influence of different supplements was performed in 2D. hPL-cultivated MSCs exhibited
a higher proliferation and differentiation rate compared to HS- or FCS-cultivated cells.
We demonstrated a fast and successful chondrogenic differentiation in the 2D system
with the addition of hPL. Additionally, FCS, HS, and hPL were used to formulate
Gelatin-methacryloyl (GelMA) hydrogels in order to evaluate the influence of the different
supplements on the cell spreading and proliferation of cells growing in 3D culture. In
addition, the hydrogel constructs were cultivated in media supplemented with three
different supplements. In comparison to FCS and HS, the addition of hPL to GelMA
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hydrogels during the encapsulation of hAD-MSCs resulted in enhanced cell spreading
and proliferation. This effect was promoted even further by cultivating the hydrogel
constructs in hPL-supplemented media.
Keywords: platelet lysate, mesenchymal stem cells, differentiation, medium supplements, fetal calf serum, human
serum, gelatin methacryloyl (GelMA), hydrogel
INTRODUCTION
More than half a century has passed since the first isolation and
in vitro cultivation of mesenchymal stem cells (MSC) described
by Friedenstein et al. (1966) and Friedenstein et al. (1970). From
that point on, numerous studies about the handling of these cells
have been performed. However, the development of an optimal
protocol for cultivating MSCs is still in progress (Spees et al.,
2016; Lavrentieva et al., 2020). The most common and most
widely used cell culture medium supplement is fetal calf serum
(FCS). It has been used for the cultivation of several cell types
for more than 50 years (Gstraunthaler et al., 2013). To date,
most cell isolation or expansion protocols for clinical studies
use FCS for supplementation (Schrödel, 2007; Lindroos et al.,
2009; Bieback, 2013; Hemeda et al., 2014; Burnouf et al., 2016;
Monsanto et al., 2017; Motedayyen et al., 2017; Araújo et al.,
2018; Lee et al., 2019; Cherian et al., 2020; Ghamari et al., 2020;
Wagner et al., 2020). Even though there are various disadvantages
related to FCS such as lot-to-lot variability, ethical concerns about
collecting the serum from the heart of unborn calves and the risk
of viral, mycoplasm or prion infections or immune responses
of the recipients toward foreign factors, there are no widely
accepted alternatives for FCS (Lindroos et al., 2009; Bieback,
2013; Jonsdottir-Buch et al., 2013; Hemeda et al., 2014; Burnouf
et al., 2016; Monsanto et al., 2017; Motedayyen et al., 2017; Lee
et al., 2019; Cherian et al., 2020; Wagner et al., 2020).
A sustained effect on the differentiation capacity and the
immunophenotype of cells has been observed in different studies
by using xeno-free autologous human serum (HS) as a medium
supplement. Due to its promoting effect on cell expansion and
its human origin, HS appears to be a potential alternative to
FCS (Mannello and Tonti, 2007). However, because of high costs
of its manufacture, the production of HS is actually decreasing
(Müller et al., 2006; Mannello and Tonti, 2007; Aldahmash et al.,
2011; Hemeda et al., 2014). Hence, the goal for the future is a
completely chemically defined MSC medium. But to date, there
is still no reliable, efficient, comprehensive and fully defined
medium available for a broad MSCs cultivation. Moreover, most
of the available defined media require additional coatings of the
cell culture surface with proteins (Pijuan-Galitó et al., 2016; Salzig
et al., 2016; Wu et al., 2016; Cherian et al., 2020). These, in turn
are often derived from animal origin, so that in this case no truly
xeno-free cultivation with these media is possible.
MSCs have a clinical potential for use in cell therapies
and tissue engineering (TE) due to their immunomodulatory
potential, stromal functions and their great proliferation as well
as differentiation capacities in vitro (Dominici et al., 2006). MSCs
can be differentiated in different cell types and the potential of
controlled chondrogenic and osteogenic differentiation of these
cells makes them promising candidates for cartilage and bone
TE, as well as for in vitro 2D and 3D models for drug screening
and disease modeling (Raic et al., 2019). Because of rising ethical,
safety and scientific concerns, the World Health Organization
andGoodManufacturing Practice (GMP) guidelines recommend
the prohibition of the use of animal-derived supplements or
supplements containing animal-sourced ingredients for stem cell
cultivations or advanced therapy medicinal products (Schrödel,
2007; Lindroos et al., 2009; Bieback, 2013; Gstraunthaler et al.,
2013; Hemeda et al., 2014). Hence, until a chemically defined
medium is available for MSCs cultivation, it is essential to
evaluate existing alternatives to FCS such as human platelet
lysate (hPL).
The first attempts to use platelet-rich plasma and platelet
lysates as cell culture medium supplement were already made
30 years ago (Gimbrone et al., 1969; Mavrina et al., 1986;
Burnouf et al., 2016). Since that time it has been shown that
hPL supports in vitro growth and osteogenic differentiation
of MSCs (Doucet et al., 2005; Lange et al., 2007; Schallmoser
et al., 2007; Bieback et al., 2009; Jonsdottir-Buch et al., 2013;
Schallmoser and Strunk, 2013; Shih and Burnouf, 2015; Siciliano
et al., 2015; Astori et al., 2016; Burnouf et al., 2016; Fernandez-
Rebollo et al., 2017), as well as the proliferation of progenitor cells
and endothelial colony forming progenitor cells (Schallmoser
and Strunk, 2013). hPL appears to be a valuable alternative to FCS
and shows several advantages, such as its easy production from
human platelet concentrate in conformity with GMP guidelines
(Burnouf et al., 2016). Moreover, the use of hPL combines
modern social principles of ethics, sustainability, recycling and
resources conservation. More than twenty percent of the platelets
donated in global blood donation programs expire before they
can be used for infusions. Since no difference was determined
between using expired or fresh hPL as medium supplements,
there is a possibility to recycle expired platelets obtained
from blood banks (Jonsdottir-Buch et al., 2013). Furthermore,
hPL contains many bioactive factors such as growth factors
and cytokines, which act synergistically to support the cell
growth, behavior and differentiation of MSCs. Moreover, hPL
has demonstrated the ability to enhance the proliferation and
differentiation of MSCs in 2D and 3D cultivations in various
studies (Supplementary Table 1) (Bieback, 2013; Jonsdottir-
Buch et al., 2013; Altaie et al., 2016; Burnouf et al., 2016;
Kirsch et al., 2019, 2020). However, commercially available hPLs
usually contain heparin in order to prevent hPL gelation. Heparin
is a product, extracted from porcine small intestine mucosa.
Thus, cell cultures grown in the presence of such hPL are no
longer xeno-free (Mojica-Henshaw et al., 2013). Furthermore,
Hemeda et al. showed that the heparin concentration is critical
for 2D MSC cultures in hPL-supplemented medium. This group
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demonstrated a concentration-dependent influence of heparin
on cell proliferation, the colony-forming unit frequency as well
as the in vitro differentiation of MSCs (Hemeda et al., 2013). In
our study, fibrinogen-depleted hPL was used without addition
of heparin to the cell culture medium, in order to maintain
true xeno-free cultivation conditions. Providing genuine xeno-
free conditions and considering these promising aspects, the
challenge is to evaluate and optimize protocols for the production
and application of hPL.
Many cell cultivation protocols are still predominantly
designed for 2D cultivation. However, compared to 2D-cultured
MSCs, 3D cell cultivation seems to be more advantageous,
because 3D growing cells reflect the in vivo environment ofMSCs
to a higher extent. Thus, physiological cell-cell and cell-matrix
contacts can be simulated and studied only in 3D cell cultures.
Moreover, considering angiogenic and immunomodulatory
factors, 3D-grown cells have a higher quality (Mark et al., 1977;
Cukierman et al., 2001, 2002; Abbott, 2003; Bissell et al., 2003;
Schmeichel and Bissell, 2003; Lee et al., 2009; Li and Cui, 2014).
Various studies have already investigated the possibility of
direct 3D isolation of MSCs from bone and adipogenic tissue
to prevent 2D cultivation of the cells (Papadimitropoulos et al.,
2014; Egger et al., 2019). Similar to 2D cell cultivation,
xeno-free alternatives to FCS are needed for 3D cell
cultivation and the influence of medium supplements must be
systematically evaluated.
In addition to cellular aggregates and cells growing on
scaffolds, hydrogels represent a very promising 3D cultivation
system. Hydrogels provide a tunable versatile platform for in
vitro 3D cultivation, TE and bioprinting (Ruedinger et al., 2015;
Pepelanova et al., 2018). Regular semi-synthetic hydrogels are
usually stored as lyophilized proteins and are reconstituted
with PBS prior cell encapsulation. Thus, they do not normally
contain any additional supplements. Regarding 3D hydrogels,
the addition of supplements to both, hydrogels and the medium
can influence cell behavior. Only a limited number of studies
have investigated the influence of direct hPL addition to
hydrogels on encapsulated MSCs (Moreira Teixeira et al.,
2012; Santos et al., 2018; Jooybar et al., 2019). Most of
these studies cultivated the hPL-containing hydrogels in media
supplemented with FCS, thus effectively not under true xeno-
free conditions (Moreira Teixeira et al., 2012; Santos et al.,
2018). So far, no study has shown the influence of different
medium supplements on the cell behavior of encapsulated
MSCs in comparison. To the best of our knowledge, no
study investigating the effect of supplementation of hydrogels
and medium on the encapsulated cells has been conducted
to date.
In the present study, the influence of hPL (2.5% hPL) on
the proliferation, as well as the osteogenic and chondrogenic
differentiation of human adipose-derived mesenchymal stem
cells (hAD-MSCs) obtained from four different donors was
systematically investigated in a 2D cultivation system.
The influence of hPL was compared to FCS (10%) and HS
(10%). Online monitoring of osteogenic differentiation in 2D
under the influence of different supplements was performed
and evaluated.
Recently, we published a study about the influence of
formulating GelMA hydrogels with different hPL concentrations
(Kirsch et al., 2019). The addition of hPL directly to the hydrogel
supported not only the cells but also had a positive impact
on the mechanical properties of the GelMA hydrogels. It was
demonstrated that the addition of hPL to the hydrogels improves
cell growth and cell adhesion. However, this beneficial effect
could have been caused by the direct formulation of the hydrogel
with a supplement carrying multiple bioactive factors, and must
not be directly related to the superior properties of a xeno-
free protocol with hPL. In order to investigate this aspect
more closely, we expanded the study by formulating GelMA
hydrogel with three different media supplements (FCS, HS, and
hPL) and studied their influence on cell growth and adhesion.
Consequently, the influence of the three supplements as direct
additions to the growth media of 3D cultivated cells was also
investigated under the aspects of cell spreading, cell morphology,
as well as cell viability.
MATERIALS AND METHODS
MSC Cultivation
Human AD-MSCs were isolated from adipose tissue of four
donors after abdominoplasty surgery. The use of human tissue
from patients (after their informed consent) has been approved
by the Institutional Review Board (Hannover Medical School,
Ref. Nr.: 3475-2017). As described earlier, we performed surface
marker analysis and functional characterization of the isolated
cell populations to characterize them as MSCs (Pepelanova
et al., 2018). hAD-MSCs were expanded in alpha-MEM medium
(Thermo Fisher Scientific, Waltham, MA, USA) and 10%
human serum (CC-pro, Oberdorla, Germany) as well as 0.5%
gentamicin (Merck Millipore, Darmstadt, Germany), harvested
by accutase treatment (Sigma Aldrich, Taufkirchen, Germany),
and cryopreserved at passage one or two until the start of
the experiment. Experiments were performed with cells of
passages two to nine. Following concentrations of cell culture
supplements were used for all performed experiments: 10% FCS,
10% HS and 2.5% hPL. hPL concentration of 2.5% was chosen
based on preliminary experiments. The tested concentrations
in preliminary experiments were 0, 1, 2.5, 5, and 10% of hPL
in medium. The highest differentiation capacity and a more
even distribution of Alizarin Red staining were observed at a
concentration of 2.5% (Supplementary Figure 1a). Furthermore,
in order to test if lower concentrated FCS or HS could also result
in higher osteogenic differentiation, 2.5% of all supplements
were used in preliminary experiments. The cell viability and
osteogenic differentiation was significantly lower for hAD-MSCs
cultivated with 2.5% FCS and 2.5% HS compared to 2.5% hPL
(Supplementary Figure 1b). Due to those results the standard
concentration of 10% FCS and HS was used to supplement the
medium in all experiments.
Platelet Lysate Preparation
Human platelet lysates were prepared and provided by the
German Red Cross Blood Service NSTOB (Springe, Germany)
by freeze-thaw treatments of pooled platelets from surplus buffy
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coats. To prevent gelation of hPL and avoid the use of heparin,
fribrinogen depletion was performed by the calcium presipitation
method, followed by filtration of the platelet lysate.
Cell Proliferation Analysis
For cell proliferation studies, the hAD-MSCs were harvested
at 80% of confluency by accutase treatment, counted using a
hemocytometer and seeded at a density of 3,000 cells/cm2 in
25 cm2 cell culture flasks containing 4ml medium. Alpha-MEM
medium was supplemented with 10% HS, 10% FCS or 2.5% hPL.
hAD-MSCs from four different donors were sub-cultivated two
times per week with a seeding density of 3,000 cells/cm2 over five
passages; cell number and viability were evaluated by trypan blue
exclusion and cumulative cell numbers were calculated.
Osteogenic and Chondrogenic
Differentiation
For differentiation experiments, cells were seeded in 24-well
plates (growth area 2 cm2, Sarstedt, Germany) at a density of
10.000 to 15.000 cells/cm2 in 500 µl alpha-MEM containing
10% HS, 10% FCS or 2.5% hPL and 50µg/ml gentamicin per
well. After seeding, cells were cultivated for 24–48 h (until full
confluence was achieved) in a humidified atmosphere containing
5% CO2 and 21% O2 at 37
◦C. Afterwards, the cell culture
medium was changed to either the osteogenic or chondrogenic
differentiation medium. Osteogenic differentiation medium
contained 5mM β-glycerophosphate, 0.1µM dexamethasone,
0.2mM L-ascorbate-2-phosphate, 0.5% gentamicin, as well as
2.5% hPL, 10% HS or 10% FCS. Serum-free chondrogenic
differentiation medium was purchased from Gibco (StemPro
Chondrogenic differentiation kit, Gibco, Germany) and also
supplemented with 2.5% hPL, 10% HS or 10% FCS. The medium
was exchanged every 3–4 days. Cells were cultured for the next
7, 14, or 21 days and then washed in PBS and fixed for 15min
at 4◦C with 4% paraformaldehyde for staining. Before fixation,
indirect cell viability was estimated by CellTiter-Blue R© (CTB)
assay according to the manufacturer’s instructions (Promega,
Mannheim, Germany). Briefly, CTB stock solution was diluted
in alpha-MEM basal medium (1:10 v/v) and added to the cells.
The fluorescence was measured after 2 h of incubation at an
extinction wavelength of 544 nm and an emission wavelength of
590 nm with a microplate reader (Fluoroskan Ascent, Thermo
Fisher Scientific Inc., Waltham, MA, USA).
Alizarin Red and Alcian Blue Staining
In order to determine the degree of osteogenic differentiation,
Alizarin Red staining was used. The fixed cell layers were
incubated in Alizarin Red solution, containing 1% Alizarin Red
S (Merck KGaA, Darmstadt, Germany) in deionized H2O, for
15min at room temperature. After washing with deionized
H2O the red chelates were detected with a microscope. The
accumulation of proteoglycans in the extracellular matrix during
the chondrogenic differentiation was visualized by using Alcian
Blue staining. Fixed cell layers were washed twice with PBS,
incubated for 3min in 3% acetic acid at room temperature,
followed by 30min incubation in Alcian Blue solution (1%Alcian
Blue 8GX, Sigma Aldrich, in 3% acetic acid) at room temperature.
After incubation, cell layers were washed several times with 3%
acetic acid and the presence of bound Alcian Blue stain was
detected using a microscope.
Alizarin Red Extraction
To quantify the degree of osteogenic differentiation, Alizarin
Red was extracted with 10% hexadecylpyridinium chloride
monohydrate (Sigma-Aldrich, St. Louis, WI, USA) in 1× PBS for
20min at 37◦C. The concentration of extracted Alizarin Red was
measured at 550 nm (Epoch, BioTek Instruments, Winooski, VT,
USA) and calculated using a calibration curve with a regression
of 0.997. If required, samples were diluted to bring Alizarin Red
concentrations within the linear range of the photometer.
Online Monitoring and Evaluation of
Osteogenic Differentiation by Image
Analysis
During the differentiation, time-lapse microscopic pictures
were taken using an IncuCyte R© Live-Cell Imaging System
(Sartorius, Göttingen, Germany) placed in the incubator. The
osteogenic differentiation of the cells was determined and
quantified by training a metric phase object confluence mask
for the typical changes in the morphology of the cells toward
osteocytes (Figure 5B). To add an enhanced coloring mask to the
images, the software (IncuCyte R© Analysis Software) provides
a processing definition step to train the algorithm to highlight
the correct markers on a limited representative set of images at
different time points and stages of the osteogenic differentiation.
This processing step can be visually inspected and adjusted to
be valid for all the pictures in the limited training set. After the
visual inspection, when the mask highlights the correct parts
where the cells are slowly changing their morphology toward
osteocytes and increasing the mineralization of the extracellular
matrix, the software can automatically analyze the images of the
total experiment. When the processing definition is valid for the
training image set, this can be used for online monitoring of
the experiment.
Alkaline Phosphatase (ALP) Assays
Next to the Alizarin Red staining and quantification, the ALP
activity was also measured in the cells as well as in the
supernatants (Anh et al., 1998). The fixated cells were incubated
with 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/nitro blue
tetrazolium (NBT) (SIGMAFAST BCIP R©/NBT, B5655, Merck,
Darmstadt, Germany) for 30min at room temperature, washed
with PBS and microscopically analyzed with an Olympus IX50
(Olympus Corporation, Tokyo, Japan). For the quantification of
the ALP activity in the supernatant 1 day before measurement,
the medium was exchanged to proliferation or differentiation
medium without supplements, in order to ensure a sensitive
measurement of the activity in the medium. As a standard
4-nitrophenol solution (10mM, Sigma-Aldrich, St. Louis, WI,
USA) was used and diluted in ALP buffer (one Trizma
R©
Buffer
tablet of SIGMAFASTTM p-Nitrophenyl phosphate dissolved in
20ml ddH2O,Merck, Darmstadt, Germany) for a standard series.
The five-fold concentrated substrate solution was prepared by
dissolving one pNPP tablet and one Trizma R© Buffer tablet of
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the kit in 4ml ddH2O. Each week, the supernatant was removed
5min centrifuged at 4◦C/14.000 rpm and 250 µl were stored
at −20◦C until further use. At the end of the experiment, all
supernatants were thawed, vortexed and 40 µl/well of each
sample, control (medium) and the standard series was added in
a 96-wellplate. After adding 10 µl of the substrate solution, the
plate was shaked for 5min at 37◦C/450 rpm and incubated for
7 h at 37◦C. After 7 h, the plate was measured at 405 nm (Epoch,
BioTek Instruments, Winooski, VT, USA) and the ALP activity
was calculated by using a calibration curve of the standard series
with a regression of 0.999.
Quantitative Glycosaminoglycan (GAG)
Assay
After 7, 14, and 21 days of culture in chondrogenic differentiation
medium, the cells were harvested and digested in 500 µl/well
papain solution [500 µl 0.1M NaH2PO4/0.005mM EDTA
(pH 6), 5 µl β-mercaptoethanol, and 2.5 µl papain (10
mg/ml, Sigma-Aldrich, St. Louis, WI, USA) at 60◦C and 800
rpm overnight. The papain digest solution was then used
to quantify the deoxyribonucleic acid (DNA) and GAGs.
A DNA standard series was prepared with DNA from calf
thymus (Sigma-Aldrich, St. Louis, WI, USA). In a 96 well
plate, 100 µl preparation buffer and then 100 µl of the
respective sample or standard series were added. After 100
µl of bisbenzimide (Sigma-Aldrich, St. Louis, WI, USA) was
added to each well, the plate was measured at 360/460 nm with
a spectrophotometer (F-7000 FL Spectrophotometer, Hitachi,
Tokio, Japan). Chondroitin sulfate (Sigma-Aldrich, St. Louis,
WI, USA) was used as a standard and 100 µl of the samples
was added to 100 µl/well ddH2O in a 96 well plate. After
adding 150 µl 1,9-dimethyl-methylene blue (DMMB, Sigma-
Aldrich, St. Louis, WI, USA) the plate was measured at
530 nm (Epoch, BioTek Instruments, Winooski, VT, USA)
and the DNA and GAG concentration was calculated with
calibration curves.
GelMA Synthesis and Hydrogel Preparation
As already described in a previous study, GelMA was synthesized
according to a previously described protocol (Pepelanova et al.,
2018). The degree of functionalization (DoF) of GelMA used in
the experiments was of 50%. GelMA solutions were prepared
at a concentration of 5% (w/v). The GelMA was dissolved
in 50% of PBS and either 50% (v/v) FCS, HS, or hPL (hPL
pH value 7.3, manufactured by German Red Cross, Blood
Service NSTOB, Springe, Germany) was added (Figure 1). After
dissolving all GelMA solutions in a water bath at 37◦C, they
were sterile filtered with 0.45µm polyethersulfone (PES) filters
and 0.1% (w/v) photoinitiator 2-Hydroxy-4
′
-(2-hydroxyethoxy)-
2-methylpropiophenone (Irgacure 2959) was added prior to the
encapsulation of cells.
Encapsulation and Cultivation of
hAD-MSCs in Hydrogels
The cells were resuspended in the GelMA solutions at a
concentration of 1.0 × 106 cells/mL and filled in 50-µL disks
(6-mm diameter) in silicon molds. With an UV intensity of
1.2 J/cm2 (polymerization time of ∼5min) the hAD-MSCs
were encapsulated in the hydrogels with the help of a cross
linker (BLX-365 Bio-Link, 365 nm, Vilber Lourmat, Germany).
The cells encapsulated in GelMA hydrogels formulated with
PBS, FCS, HS, and hPL were further cultivated in medium
supplemented with 10% FCS, 10% HS, or 2.5% hPL (Figure 1).
The preparation of the well-plates and the handling of the
hydrogels is described earlier (Kirsch et al., 2019). As described
in more detail in our previous study, the indirect cell viability
was determined by the CellTiter-Blue R© (CTB) (Promega,
Mannheim, Germany) assay according to the manufacturer’s
specifications (Kirsch et al., 2019). For morphological analysis,
encapsulated cells were cultivated for one, three or seven days,
incubated in basal alpha-MEMwith the addition of 4µMcalcein-
acetoxymethyl (AM) (Merck, Darmstadt, Germany) for 40min
at 37◦C. The hAD-MSCs were analyzed with a Cytation 5-Cell
Imaging Multi-Mode Reader (Biotek Instruments, Winooski,
VT, USA).
Statistical Analysis
The data are presented as mean value ± standard deviation
of the multiple measurements/counts of each sample. A one-
way ANOVA (OriginLab) was performed to determine the
statistical significance of the measured values, defined as p-value
of ∗p < 0.05, ∗∗p < 0.01, or ∗∗∗p < 0.001.
RESULTS
hAD-MSCs Proliferation in 2D
To evaluate the influence of hPL on hAD-MSCs proliferation,
cells isolated from four different donors were cultivated over
five passages in alpha-MEM supplemented with 2.5% hPL
FIGURE 1 | Schematic representation of 3D hydrogel-based cultivation: first
GelMA hydrogels were formulated with 50% FCS, 50% HS, or 50% hPL
followed by cultivation in medium supplemented with 10% FCS, 10% HS, or
2.5% hPL.
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and compared to the cell growth in conventional cell culture
conditions: medium with 10% FCS and 10% HS. Differences in
the cell growth of the various donors are caused by biological
variations. Figures 2A–D, that three of the four donor cells
cultivated in medium supplemented with hPL show the highest
total cell number compared to FCS and HS as supplements.
Especially during the first passages, the increase of cell number
was highest for cells cultivated in hPL-containing medium. Cells
cultivated in medium supplemented with FCS exhibited the
lowest cell number and cell division for all donors.
To ensure that hAD-MSCs had not changed their typical
immunophenotype during the cultivation with different
supplements, a flow cytometry analysis for characteristic MSC-
markers was performed and revealed no changes in specific
marker expression (Supplementary Table 2).
The obtained results demonstrate that medium supplemented
with hPL provide a significant higher cell proliferation of hAD-
MSCs for three of four donors compared to HS and in all four
donors compared to FCS as a supplement. The cumulative cell
number after cultivation with hPL was twice to more than five
times higher than the cell number after cultivation with FCS.
In a short period of time the cell number can be increased
significantly, which underlines the potential of hPL-containing
medium for rapid MSCs expansion.
Osteogenic Differentiation
The cells were cultivated in differentiation medium
supplemented with FCS, HS, or hPL over three weeks. Despite
the higher amount of supplements (10% of volume), cells
cultivated in medium with conventional supplements (FCS
FIGURE 2 | The influence of cell culture supplements on the long-term cultivation of hAD-MSCs. Cells from four donors [(A) Donor 1, (B) Donor 2, (C) Donor 3 and (D)
Donor 4] were cultivated over five passages in 2.5% hPL (black line), 10% HS (light gray dotted line) or 10% FCS (gray dashed line) and cumulative cell numbers were
calculated. *p < 0.05, **p < 0.01, ***p < 0.001 (*, **, *** indicates significant difference to FCS); ¤p < 0.05, ¤¤p < 0.01 (¤, ¤¤ indicates significant difference to HS).
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and HS) only showed an irregular Alizarin red staining after
three weeks. As illustrated in Figure 3, only MSCs differentiated
in medium supplemented with hPL showed an accumulation
of calcium already after 1 week of cultivation visualized by
Alizarin red staining. The staining was even more intense and
homogenously distributed after 3 weeks of cultivation. hAD-
MSCs from all donors exhibited an osteogenic differentiation in
all used supplements after 3 weeks of stimulation. These results
were also confirmed by the quantification of Alizarin red staining
during the whole period of differentiation (Figure 3B). Only hPL
as a supplement was able to induce osteogenic differentiation
during the first week of cultivation. As illustrated in Figure 3C,
the indirectly measured viability of cells remained high and did
not change significantly over 3 weeks with all three medium
supplements. In addition to the staining and quantification of
Alizarin red, the ALP activity was measured in the supernatant
and in the cells (Figure 4). Only cells differentiated with hPL
containing medium showed ALP -positive cells already after 1
week (Figure 4A). In comparison, fewer ALP-positive cells were
observed in FCS and HS differentiated cells. The quantitative
determination of ALP activity in the supernatant showed
the lowest activity each week in cells differentiated in FCS
(Figure 4B). In HS differentiated cells, low ALP activity could
be measured after seven days of differentiation. The highest ALP
activity was detectable in the supernatant of cells differentiated
in hPL-supplemented medium.
Online monitoring and the evaluation of osteogenic
differentiation dynamics with the help of a trained metric phase
object confluence mask also revealed the superiority of hPL in
terms of the onset of calcium deposition (Figure 5). However,
FIGURE 3 | (A) Alizarin red staining of the hAD-MSCs from four donors differentiated in the presence of 2.5% hPL, 10% HS, or 10% FCS. The influence of cell culture
supplements on the calcium deposition evaluated by Alizarin red extraction, 10× objective, scale bar 100µm. (B) and on the cell viability during the differentiation (C).
Data represent the mean ± SD of a threefold determination for four donors.
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FIGURE 4 | (A) Alkaline phosphatase staining of differentiated hAD-MSCs cultivated for 7, 14, and 21 days and differentiated in medium supplemented with FCS, HS
and hPL, 10× objective, scale bar 100µm. (B) Measured ALP activity in the supernatant of hAD-MSCs cultivated with FCS, HS and hPL for 7, 14, and 21 days. Data
represent the mean ± SD of a threefold determination for two donors.
in comparison to the Alizarin red staining in the unstained live
MSCs culture, the software first recognized the deposition after
day seven.
Chondrogenic Differentiation
Traditionally MSCs are only able to differentiate into
chondrocytes when cultivated in pellet 3D cultures. In this
study, hPL supported chondrogenic differentiation of hAD-
MSCs also in 2D cultivations system (Figure 6). If media
were supplemented with FCS or HS, hAD-MSCs of all tested
donors did not show accumulation of proteoglycans after the
chondrogenic stimulation (Figure 6A). Under FCS and HS
cultivation conditions, cells started to detach from the cell
culture surface and to agglomerate already after 2 weeks of
differentiation. In the presence of hPL, cells from all tested
donors started to accumulate proteoglycans already after 2
weeks of stimulation, as demonstrated by the positive Alcian
Blue staining. After 2 weeks of stimulation, an increased GAG
production was measured in the presence of hPL (Figure 6B).
hAD-MSCs cultivated with hPL-supplemented differentiation
medium showed the highest GAG/DNA ratios during the
entire period of differentiation. These data demonstrate
that the sole presence of hPL in chondrogenic medium can
induce chondrogenic differentiation and accumulation of
glycosaminoglycans by hAD-MSCs.
Comparative Analysis of the Influence of
Different Medium Supplements in 3D
Cultivation
To compare the influence of different supplements on hAD-
MSCs cultivated in hydrogels, both addition of supplements
directly into hydrogels and addition of supplements to the media
were investigated (Figure 1). To evaluate the cell growth and
behavior, the morphology as well as the metabolic activity of the
cells was measured (CTB).
In almost all GelMA hydrogels, increased cell spreading was
visible from day three to day seven (Figure 7). The lowest
amount of spreading after seven days was observed when
hAD-MSCs were encapsulated in GelMA prepared in PBS
with the addition of 50% FCS. When additionally cultivated
with FCS-supplemented medium, spreading cells were rarely
seen 7 days (Figure 7A) and only a few elongated cells were
visible after 7 days in the HS or hPL-supplemented medium
(Figures 7B,C). In contrast, the addition of HS to the hydrogel
had a positive influence on the cell spreading in FCS, HS and
hPL-supplemented medium (Figures 7A–C). Encapsulating the
cells in GelMA with the addition of 50% hPL led to a more
distinct cell spreading in all tested culture media. A few elongated
cells could be observed already on day one with most cells
showing extensive spreading after 7 days. In hPL-supplemented
medium, cells were elongated and formed a three dimensional
homogenous cell network.
The metabolic activity in all hydrogels increased over the
cultivation time (Figure 7D). Cells encapsulated in GelMA
hydrogels formulated with 50% FCS showed the lowest
viability in all media, cells encapsulated in GelMA hydrogels
formulated with 50% hPL demonstrated the highest viability.
Formulating the hydrogels with 50% hPL instead of FCS led
to an almost doubled cell viability when cultivated in FCS-
supplemented medium. Regarding the media supplementation,
supplementation with HS led to the lowest cell viability
compared to the supplementation of FCS and hPL. However,
in comparison to FCS-supplemented medium, hAD-MSCs
cultivated in hPL-supplemented medium did not show a
cell viability increase from day three to day seven. Overall,
the cultivation of cells in GelMA hydrogels formulated with
50% FCS, in combination with HS-supplemented medium,
represents the worst combination. The best combination,
with the highest cell viability, was shown by GelMA
hydrogels dissolved in 50% hPL, when cultivated in FCS- or
hPL-containing medium.
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FIGURE 5 | (A) The influence of cell culture supplements on the calcium deposition evaluated by using a trained metric phase object confluence mask for microscopic
pictures analyzed by the IncuCyte Live-Cell Imaging System and Software (Essen BioScience, Ann Arbor, MI). Data represent the mean ± SD for a fourfold
determination. (B) Microscopic pictures taken by an IncuCyte Live-Cell Imaging System and blended with a trained metric phase object confluence mask, which
indicates typical osteogenic changes of the cells, scale bar 400µm.
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FIGURE 6 | (A) Alcian Blue staining of the hAD-MSCs from four donors differentiated in the presence in 2.5% hPL, 10% HS, or 10% FCS. 10× objective, scale bar
100µm. (B) Determination of the GAG deposition in cells (in µg GAG/µg DNA) differentiated for 7, 14, and 21 days under influence of FCS, HS, and hPL. Data
represent the mean ± SD of two independent experiments in threefold determination for two donors.
FIGURE 7 | Morphological examination (A–C) and cell viability (D) of hAD-MSCs encapsulated with a UV dose of 1.2 J/cm2 in 5% GelMA with 50% degree of
functionalization (DoF) formulated with 50% PBS and 50% FCS, 50% HS, or 50% hPL. The hydrogels were cultivated in (A) FCS, (B) HS, or (C) hPL supplemented
medium. After cultivating the cells for 1, 3, and 7 days, they were stained with calcein-AM; 4× objective, scale bar 500µm. (D) The CellTiter-Blue (CTB) assay was
performed on day 1, day 3, and day 7 of cultivation. Data represent the mean ± SD for a threefold determination. *p < 0.05, **p < 0.01, ***p < 0.001.
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DISCUSSION
Cultivation of human cells, including MSCs, in FCS-
supplemented media raises concerns since cells cultivated
with animal supplements can cause xenogenic immune
reactions and transmit prions or other zoonotic infections
after transplantation (Bottio et al., 2003; Capelli et al., 2007;
Astori et al., 2016). Moreover, the large-scale manufacturing
of these cells requires large amounts of clinical grade FCS,
which is in limited supply. The use of serum-free media
would be the best choice, however, at the moment only few
chemically defined, serum-free media are available on the
market (e.g., MSCGM-CDTM media from Lonza). The term
“serum-free,” however, does not always mean that the media
does not contain supplements of animal or human origin.
Moreover, not every chemically defined medium supports
cell growth of all kind of MSCs (MSCs of different origin).
For example, it has been demonstrated that Mesencult-XF
supports growth of hAD-MSCs, but not of bone marrow-derived
mesenchymal stem cells (Al-Saqi et al., 2014). Until efficient
“real” serum-free media are developed, it is essential to establish
xeno-free systems for in vitro expansion of primary human
cells, including MSCs. At the moment, more than 1,100 clinical
trials are listed where MSCs from different sources are involved
(clinicaltrials.gov). Treatment with MSCs often requires an
in vitro cell expansion step to reach clinically relevant cell
numbers. For each treatment, the individual cell dosage is
estimated to be 105-109 cells (Simaria et al., 2014). In addition,
the expanded MSCs should retain their biological activity (e.g.,
immunomodulating properties, differentiation capacity and
stromal/rescue function). Thus, it is indispensable to have an
efficient xeno-free in vitromedia to expand these cells for clinical
trials and later for therapies.
An additional factor which affects the cell quality is the applied
cultivation system. As shown in various studies, the chosen
cultivation system influences cell behavior and cell functionality,
such as the expression of specific factors (Mark et al., 1977;
Cukierman et al., 2001, 2002; Abbott, 2003; Bissell et al., 2003;
Schmeichel and Bissell, 2003; Lee et al., 2009; Li and Cui, 2014;
Papadimitropoulos et al., 2014; Sart et al., 2014; Egger et al.,
2019). Therefore, the application of xeno-free in vitro media
should be combined with cell cultivation in a 3D cultivation
system, in order to obtain the best possible replication of the
physiological cell state.
In the present work, the influence of hPL on proliferation
and differentiation of hAD-MSCs in 2D cultivation systems
was investigated and the obtained results were systematically
compared with cells cultivated with HS and FCS. In this study,
we revealed that the 2D supplementation of cell culture medium
with 2.5% hPL accelerated cell proliferation during the first 2–
3 passages. Cells isolated from all four tested donors expanded
in 2D faster in the presence of 2.5% hPL than in the presence
of 10% HS or 10% FCS. Although differences in proliferation
capacities could be observed in each donor, the application of hPL
will allow each donor to reach the fastest cell expansion. These
results were demonstrated earlier for MSCs isolated from human
bone-marrow, umbilical cord blood and adipose tissue (Blande
et al., 2009; Shih et al., 2011; Bieback, 2013; Astori et al., 2016). It
is important to note that not only supplements (serum) play an
essential role in the expansion efficiency, but also the basal media
composition. In addition, the right combination of basal media,
supplements and seeding strategy is critical to obtain optimal
conditions for in vitro cell growth (Kasper et al., 2018). In our
work, αMEM was used, which is more physiological than the
widely used high glucose DMEM or RPMI media.
Human platelets in vivo play a major role in homeostasis and
represent a rich source of survival and growth factors, which are
usually released during wound healing at the site of injury (Shih
and Burnouf, 2015). Therefore, hPL could provide an efficient
replacement for FCS and HS (Hemeda et al., 2014). Siciliano et al.
performed the isolation and successful 2D expansion of human
mediastinal hAD-MSCs in virally inactivated GMP-grade hPL
(Siciliano et al., 2015). They demonstrated that mediastinal hAD-
MSCs cultivated in 10–20% hPL had higher growth rates than the
ones cultivated in FCS. In comparison to the above-mentioned
study, we could reach the same effect by cultivating the cells with
only 2.5% hPL in 2D.
In this work, we also demonstrated that hPL accelerates
osteogenic and chondrogenic differentiation in 2D cultures of
hAD-MSCs. Cells cultured with hPL remained viable during
the entire period of differentiation. The CTB assay is regarded
as an indirect measure of viability and proliferation. Since
proliferation rate is significantly reduced after induction of
differentiation, the low CTB values within hPL supplemented
cultures indicate absence of further proliferation and initiation
of osteogenic differentiation.
Furthermore, cells from all four donors accumulated calcium
in the extracellular matrix already after 1 week of osteogenic
stimulation. Concentrations of the extracted Alizarin red were
20 times higher than those measured after cell differentiation in
HS and FCS. ALP activity could be detected after the first week,
when cultured with hPL-supplemented differentiation medium.
In this study, we could monitor the changes in extracellular
matrix morphology during osteogenic differentiation online.
By training an algorithm with the software of IncuCyte R©
Live-Cell Imaging and Analysis, the increase of mineralization
over time was detected by adding a coloring mask to the
images. Using the trained mask, the software first recognized
calcium deposition after seven days and evenly distributed
early mineralization could be detected after only 10 days. This
finding of 2D differentiated cells is in line with the results of
previous studies that used hPL for 3D cell culture (Kirsch et al.,
2019, 2020; Re et al., 2019). Santo et al. demonstrated that
scaffolds loaded with hPL supported accelerated differentiation
of hAD-MSCs (Santo et al., 2012). Another group used platelet-
functionalized polycaprolactone scaffolds to enhance osteogenic
differentiation of MG-63 cells (Rampichová et al., 2017). Altaie
et al. reported that osteoconductive scaffolds colonized with
hPL-expanded MSCs show a good capability to cure bone
deficiencies in vivo in pre-clinical studies (Altaie et al., 2016).
Since CTB was used, it is not possible to differentiate between
the proliferation and metabolic activity directly. In further
experiments, the cell proliferation and direct cell viability during
differentiation could be measured, in order to distinguish
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directly between cell number and the metabolic activity of
cells differentiating under the influence of the three different
medium supplements.
In the case of chondrogenic differentiation in the 2D
cultivation system, only cells cultivated in hPL-containing
mediumwere positively stained with Alcian blue. The production
of GAG could be already measured in the second week, if
cultivated in the presence of hPL. In addition, hPL cultivated cells
demonstrated the highest GAG/DNA ratios during the entire
period of differentiation. Moreover, the Alcian blue staining was
already positive after 2 weeks of stimulation. It is well-known
that for most of the protocols for chondrogenic differentiation,
cell pellets or 3D constructs need to be created in order to
achieve a successful differentiation. In this work, the addition of
hPL was sufficient for chondrogenesis in a 2D system. Merceron
et al. were unable to detect any GAG production by hAD-
MSCs cultured in 2D (Merceron et al., 2011). Only chondrogenic
differentiated cells in 3D pellet cultures showed GAG synthesis
and accumulation. In our study, we could show a clear Alcian
blue staining, as well as a GAG production of cells differentiated
with hPL in 2D. Earlier, Feng et al. demonstrated that 10% hPL
could improve chondrogenic differentiation of umbilical cord-
derived MSCs in 3D pellets (Feng et al., 2011). It is known
that platelets contain numerous growth factors involved in
chondrogenesis such as transforming growth factor-β1, vascular
endothelial growth factor (VEGF), platelet-derived growth factor
(PDGF), insulin-like growth factor 1 (IGF-1), and insulin-like
growth factor 2 (IGF-2) (Kabiri et al., 2014). Several groups
also demonstrated a positive influence of platelet-rich plasma on
chondrogenesis of various MSCs in terms of increased collagen
II production as well as upregulation of SOX9 and Aggrecan
(Mishra et al., 2009; Xie et al., 2012; Kabiri et al., 2014). Since
chondrogenic differentiation of MSCs represents a promising
strategy for cartilage regeneration or replacement, application of
hPL can provide good conditions for effective in vitro induction
of chondrogenesis (Boeuf and Richter, 2010). 2D culture
applications of osteogenic and chondrogenic differentiatedMSCs
may be of special interest for high-throughput screening. For
instance, they could be used for drug screening in bone and
cartilage disease models. Furthermore different studies have
shown that osteogenic or chondrogenic pre-differentiated MSCs
in 2D can produce cartilage and bone tissue in vivo in the
same degree as MSCs pre-differentiated in 3D (Merceron et al.,
2011).
In addition to the need for xeno-free 2D cell culture protocols,
the demand for xeno-free cultivation protocols for 3D cell
cultures is also increasing. In the case of hydrogel-based 3D
cultivation systems, supplements can be added not only to
the medium, but also directly during hydrogel formulation.
Although 3D cell cultures with hPL as medium supplement have
been studied, there are still certain areas that require further
investigation. There are only a limited number of studies which
investigated and compared the effect of different supplements
on MSCs in general 3D cell culture systems and there are no
studies about supplement addition directly to hydrogels (Santos
et al., 2018; Kirsch et al., 2019; Re et al., 2019). In a recent
study, we have demonstrated that the supplementation of GelMA
hydrogels with different hPL concentrations had a positive effect
on cell spreading, proliferation and differentiation, as well as on
the material properties such as viscosity, storage modulus and
swelling ratio (Kirsch et al., 2019).
With this work we have shown that not only the addition
of the supplement to hydrogels, but also the supplement origin
plays an important role in cell spreading and growth. Due to
the direct addition of supplements to the hydrogels, proteins
do not have to diffuse into the hydrogels from the media, and
growth factors, adhesion factors and other bioactive proteins are
directly accessible to encapsulated cells. In this work we could
show that especially the addition of hPL to the hydrogel led to
better cultivation conditions for the cells.
In situ formulation of hydrogels with hPL increased the
cell spreading of hAD-MSCs compared to FCS- and HS-
formulated hydrogels. Supporting our previous findings, hPL
in hydrogels led to cell attachment and spreading after only
1 day of cultivation in 3D (Kirsch et al., 2019). In contrast,
FCS and HS did not show a general positive influence on cell
spreading and cell viability in hydrogels. Several studies have
previously shown a hPL-dependent or hPL-supported increase
of the proliferation rate and cell number of cells growing
on the surface or encapsulated in hPL-containing gels (hPL
gels/matrix) and hydrogels (Walenda et al., 2012; Babo et al.,
2016; Fortunato et al., 2016; Egger et al., 2019; Re et al., 2019). In
addition, the hPL enhanced cell spreading of cells encapsulated
in hydrogels was previously observed (Fortunato et al., 2016;
Santos et al., 2018; Jooybar et al., 2019). MSCs belong to the
anchorage-dependent cells. Therefore, increased cell adhesion
and enhanced cell spreading have a major impact on migration,
proliferation and differentiation of MSCs (Lauffenburger and
Horwitz, 1996; Trappmann et al., 2012; Wang et al., 2016;
Yang et al., 2019). One reason for the positive effect of hPL
on the cell attachment and spreading in the hydrogel could be
the α-granules of platelets (Kirsch et al., 2019). The α-granules
contain many different adhesion proteins, such as vitronectin,
fibronectin, thrombospondin and von Willebrand factor, which
are released during the platelet lysis (Sander et al., 1983; Wencel-
Drake et al., 1985; Kore-Grodzicki et al., 1988; Heijnen and
van der Sluijs, 2015; Burnouf et al., 2016). Another possible
reason could be the different stiffness of the matrix material,
which was shown to increase with higher hPL concentrations
in the hydrogel (Kirsch et al., 2019). Indeed, several studies
described the effect of the material stiffness from different
matrices on the cell behavior of MSCs, embryonic stem cells and
fibroblasts (Engler et al., 2004; Solon et al., 2007; Chowdhury
et al., 2010; Park et al., 2011; Sun et al., 2018). For instance,
Sun et al. demonstrated that a higher stiffness of fibronectin-
coated polyacrylamide hydrogels led to greater spreading and
adherence of BM-MSCs, as well as to an increased proliferation
rate (Sun et al., 2018). However, the exact reason for the
positive influence of hPL on cell adhesion and cell spreading
in GelMA hydrogels needs to be investigated in more detail in
further studies.
The most promising combinations for enhanced cell
spreading and increased cell proliferation were observed by
hAD-MSCs encapsulated in hydrogels formulated with 50% hPL
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cultivated in medium supplemented with 10% FCS or 2.5% hPL.
For clinical studies and applications, however, the use of xeno-
free cultivation methods is crucial. Therefore, the more suitable
xeno-free 3D cultivation protocol would be the cultivation
of MSCs in hydrogels formulated with 50% hPL in medium
supplemented with 2.5% hPL. Since allogenic and autologous
hPL can be added as a supplement to the hydrogel, but also to the
medium, individualized xeno-free off-the-shelf TE constructs
can be realized on the long-term using this optimized protocol.
In this study, the focus of the 3D experiments was to study and
compare cell behavior (morphology, cell spreading andmetabolic
activity) under all possible combinations of supplements
added to the medium or during hydrogel formulation. In
further experiments the influence of all possible supplement
combinations on the differentiation of the encapsulated cells
should be investigated.
The advantages of hPL compared to FCS and HS
demonstrated in this work regarding the support of osteogenic
and chondrogenic differentiation of MSCs in 2D in vitro
cultivations must be investigated in further studies for 3D
cultivation systems. For example, immunohistological staining
of differentiation specific markers can be performed inside
the hydrogel, as well as after the preparation of cryosections.
Cryosections can be histochemically stained for osteogenic (e.g.,
calcium or alkaline phosphatase activity) and chondrogenic
(e.g., collagen, proteoglycan, or glycosaminoglycan) specific
markers. Moreover, the hydrogels can also be enzymatically
digested in order to liberate encapsulated cells and allow the
performance of cell analysis protocols like gene microarray
analysis or flow cytometry.
CONCLUSION
Our work demonstrated that medium supplementation with
2.5% hPL is favorable for cultivation of hAD-MSCs in 2D
systems and accelerates proliferation as well as osteogenic and
chondrogenic differentiation of these cells. To our knowledge, the
progress of osteogenic differentiation under the influence of three
different supplements was monitored and evaluated in 2D for
the first time. Both, osteogenic and chondrogenic differentiation
was already detectable after 1 week of stimulation. In 3D systems,
we could show that hAD-MSCs in hPL-supplemented hydrogels
cultivated with hPL-supplemented medium adhere and spread
faster and in higher numbers when compared to FCS and HS
as supplement in hydrogels or medium. This indicates that
hPL can be a possible xeno-free alternative to the widely used
FCS not only in 2D, but also in hydrogel-based 3D cultivation
protocols. Until efficient chemically defined serum-freemedia are
established and approved for the large-scale MSCs production
and differentiation, hPL can serve as a suitable supplement for
xeno-free cell cultivation in 2D and 3D. Produced under optimal
conditions of standardization and safety, hPL can become a key
supplement for ex vivo production of MSCs and ex vivo tissue
formation for applications in the field of regenerative medicine.
As yet, the precise hPL composition and the reason for fast MSCs
differentiation in hPL are unclear.
Further studies including hPL fractionation, protein
separation and MS-analysis must be performed in order to
elucidate the positive effects of individual components of hPL
and for the creation of defined supplements. Taken together, the
application of hPL in 2D and 3D in vitro cultivation of MSCs
appears to be a promising approach for bioregenerativemedicine.
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